Young researcher in the lab
Moritz Weigl, a biotechnologist and Schrödinger Fellow, is researching the potential of microRNAs to open up new perspectives on wound healing, aging, and cancer treatment. © private

The discovery of microRNAs by Victor Ambros and Gary Ruvkun in the early 1990s fundamentally changed our understanding of gene regulation and was recently recognized with the 2024 Nobel Prize in Physiology or Medicine. Yet, more than three decades after their discovery, fundamental questions about how microRNAs function within living tissues remain unanswered.

I have long been fascinated by how microRNAs silence genes and by the intricate molecular machinery behind this process. When I was offered the opportunity to join Andrea Ventura’s laboratory at Memorial Sloan Kettering Cancer Center in New York, I was excited to take the chance and contribute to answering some of these fundamental questions.

A sophisticated system of bookmarks

MicroRNAs are small RNA molecules that help regulate which genes are active in a cell. They do this by joining specialized proteins to form a molecular machine called the microRNA-induced silencing complex, or miRISC. For many years, scientists have largely assumed that this machinery is continuously at work and required for fine-tuning gene expression in virtually every cell of our body.

One way to think about microRNAs is as a sophisticated system of bookmarks. Almost every cell in our body contains the same genetic "book", but different cells need to read different chapters. MicroRNAs contribute to organizing this information by silencing certain genes, helping cells use the right instructions at the right time.

Research in Andrea Ventura’s laboratory challenged our understanding of when this system actually is needed. Building on previous work from the Gunter Meister laboratory at the University of Regensburg, they developed a clever genetic trick that, for the first time, made it possible to globally and reversibly switch off the activity of microRNAs in living mice.

A research team against the backdrop of the New Jersey skyline.
The Ventura Laboratory at a retreat of the Memorial Sloan Kettering Cancer Center (Department of Cancer Biology and Genetics) in New Jersey. © private

When cells lose their bookmarks

Returning to the book analogy, this is kind of like scrambling an entire, carefully organized system of bookmarks. One might expect cells to lose track of which “chapters” they are supposed to read, severely disrupting normal tissue function or even promoting cancer. Surprisingly, that was not what happened. Many tissues continued to function remarkably normally, even when microRNA activity was blocked. The importance of those “bookmarks” became apparent when tissues were challenged and needed to regenerate. Under these conditions, microRNAs suddenly became essential.

Do microRNAs work on demand?

This suggested something intriguing: perhaps cells do not rely as heavily on microRNAs as previously assumed. Instead, we may need to reconsider their role, not as a system that continuously fine-tunes gene expression, but as a molecular switch that cells can turn on when they need to rapidly adapt to change, such as during wound healing. This observation informed a fundamental question that fascinated me: Could microRNAs be particularly important not for maintaining a cell’s identity as previously thought - but instead for actually suppressing it, allowing it to change its behavior or even adopt a new identity when needed?

Wound healing provides a great system to investigate this idea. Following an injury, regenerative cells in the skin must rapidly adapt to changing conditions. They multiply, migrate into the wound, and can even alter aspects of their identity to repair damaged tissue.

Advances in methodology

To investigate the role of microRNAs in this process, I developed a new mouse model that allows microRNA activity to be temporarily switched off specifically in the regenerative cells of the skin. The Erwin Schrödinger Fellowship was instrumental in making this research possible. Moving to Memorial Sloan Kettering Cancer Center gave me the opportunity not only to pursue these questions in one of the world’s leading cancer research environments, but also to learn new experimental techniques. For example, I was trained in genetically manipulating mouse embryonic stem cells and use them to generate genetically engineered mouse models.

A Mouse Model crosses the Atlantic

What makes the Erwin Schrödinger Fellowship particularly special is that it enables researchers not only to acquire new knowledge and skills abroad, but also to bring them back to Austria. In my case, this transfer was quite literal: the genetically engineered mice I developed in New York made the journey across the Atlantic to Vienna.

Today, I am using this mouse model in the Ogrodnik Laboratory at the Ludwig Boltzmann Institute for Traumatology to investigate a deceptively simple question: Which cellular processes in the skin actually depend on microRNA activity, and why?

By better understanding when and how cells rely on this molecular machinery, I hope to uncover fundamental principles of how cells adapt to change, with potential implications for our understanding of tissue regeneration, aging and cancer.